Robert J. Motzer
Impact in
- Pulmonary and Respiratory Medicine top 0.01%
- Renal cell carcinoma treatment
- Cancer Research top 0.01%
- Cancer Genomics and Diagnostics
Papers in
-
- Renal cell carcinoma treatment 670
- Cancer Research 315
- Cancer Genomics and Diagnostics 294
- Co-authors
- George J. BoslPaul RussoRobert A. FiglinThomas E. HutsonJennifer BacikMadhu MazumdarM. Dror MichaelsonRonald M. Bukowski
- Journals
- Journal of Clinical Oncology (371 papers)Annals of Oncology (58 papers)The Journal of Urology (52 papers)Cancer (32 papers)European Journal of Cancer (22 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Robert J. Motzer
905 papers receiving 57.4k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Pulmonary and Respiratory Medicine 39.4k
- Cancer Research 17.7k
- Oncology 19.5k
- Molecular Biology 30.6k
- Surgery 12.6k
Countries citing papers authored by Robert J. Motzer
This map shows the geographic impact of Robert J. Motzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Motzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Motzer more than expected).
Fields of papers citing papers by Robert J. Motzer
This network shows the impact of papers produced by Robert J. Motzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Motzer. The network helps show where Robert J. Motzer may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert J. Motzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 15 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 18 | |
| 4 | 2022 | 13 | |
| 5 | 2019 | 156 | |
| 6 | 2018 | 18 | |
| 7 | 2018 | 45 | |
| 8 | 2018 | 48 | |
| 9 | 2018 | 45 | |
| 10 | 2018 | 121 | |
| 11 | 2014 | 156 | |
| 12 | Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial Hit paper breakdown → | 2014 | 865 |
| 13 | 2014 | 187 | |
| 14 | 2013 | 267 | |
| 15 | 2012 | 55 | |
| 16 | 2011 | 148 | |
| 17 | 2010 | 27 | |
| 18 | 2010 | 147 | |
| 19 | Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma Hit paper breakdown → | 2009 | 1711 |
| 20 | Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma Hit paper breakdown → | 2005 | 1304 |
About Robert J. Motzer
Robert J. Motzer is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Molecular Biology and Surgery, having authored 932 papers that have together received 58.6k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (670 papers), Renal and related cancers (296 papers), Cancer Genomics and Diagnostics (294 papers), Testicular diseases and treatments (172 papers), Cancer Immunotherapy and Biomarkers (134 papers), Economic and Financial Impacts of Cancer (120 papers), Pancreatic and Hepatic Oncology Research (94 papers) and Neuroblastoma Research and Treatments (73 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (39.4k citations), Cancer Research (17.7k citations), Oncology (19.5k citations), Molecular Biology (30.6k citations) and Surgery (12.6k citations). Robert J. Motzer has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include George J. Bosl, Paul Russo, Robert A. Figlin, Thomas E. Hutson, Jennifer Bacik, Madhu Mazumdar, M. Dror Michaelson, Ronald M. Bukowski, Toni K. Choueiri and Stéphane Oudard. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, The Journal of Urology, Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.